Naimo Phillip S, Fricke Tyson A, d'Udekem Yves, Cochrane Andrew D, Bullock Andrew, Robertson Terry, Brizard Christian P, Konstantinov Igor E
Department of Cardiothoracic Surgery, Royal Children's Hospital, Melbourne, Australia; Department of Paediatrics, University of Melbourne, Melbourne, Australia; Murdoch Children's Research Institute, Melbourne, Australia.
Department of Cardiothoracic Surgery, Monash Medical Centre, Melbourne, Australia.
Ann Thorac Surg. 2016 May;101(5):1842-8. doi: 10.1016/j.athoracsur.2015.11.020. Epub 2016 Feb 18.
Anomalous left coronary artery from the pulmonary artery (ALCAPA) is a rare congenital heart defect with limited data on long-term outcomes after surgical intervention.
We conducted a retrospective review of all children (N = 42) who underwent surgical repair of ALCAPA between 1980 and 2014 at the Royal Children's Hospital, Melbourne.
Twenty-nine (69% [29 of 42]) patients underwent coronary reimplantation, 12 (29% [12 of 42]) had intrapulmonary baffle (Takeuchi) repair, and 1 (2% [1 of 42]) patient had ligation of the anomalous coronary artery. Nine (21%, 9 of 42) patients had concomitant mitral valve (MV) repair at the time of ALCAPA repair. A left ventricular assist device (LVAD) was used in 36% (15 of 42) of patients. Early mortality was 2.4% (1 of 42 patients). Median follow-up was 14 years (mean, 13 years; range, 4 months-31 years). There were no late deaths. Survival was 98% at 20 years. Freedom from reoperation was 81%, 81%, and 76% at 5, 10, and 20 years after operation, respectively. Eight patients underwent late MV repair or replacement at a median of 3 years (mean, 8 years; range, 2 months-25 years) after operation. Freedom from late MV repair or replacement was 86% at 5 and 10 years and 81% at 20 years after operation. Eleven (26% [11 of 42]) patients had severe mitral regurgitation (MR) preoperatively. Of those 11 patients, 5 (45% [5 of 11]) had concomitant MV repair at the time of ALCAPA repair, 3 (27% [3 of 11]) had late MV repair or replacement, and the remaining 3 (27% [3 of 11]) patients had mild MR at last follow-up. Thirty-six (90% [36 of 41]) patients had normal left ventricular function and 4 (10% [4 of 41]) patients had mildly reduced left ventricular (LV) function at last follow-up.
ALCAPA can be operated on with good outcomes. Persistent MR and a moderate rate of late MV repair warrants close follow-up.
起源于肺动脉的异常左冠状动脉(ALCAPA)是一种罕见的先天性心脏缺陷,关于手术干预后长期预后的数据有限。
我们对1980年至2014年期间在墨尔本皇家儿童医院接受ALCAPA手术修复的所有儿童(N = 42)进行了回顾性研究。
29例(69%[42例中的29例])患者接受了冠状动脉再植入术,12例(29%[42例中的12例])进行了肺内挡板(竹内)修复,1例(2%[42例中的1例])患者进行了异常冠状动脉结扎术。9例(21%,42例中的9例)患者在ALCAPA修复时同时进行了二尖瓣(MV)修复。36%(42例中的15例)的患者使用了左心室辅助装置(LVAD)。早期死亡率为2.4%(42例患者中的1例)。中位随访时间为14年(平均13年;范围4个月至31年)。无晚期死亡病例。20年生存率为98%。术后5年、10年和20年再次手术的自由度分别为81%、81%和76%。8例患者在术后中位时间3年(平均8年;范围2个月至25年)接受了晚期MV修复或置换。术后5年和10年免于晚期MV修复或置换的比例为86%,20年为81%。11例(26%[42例中的11例])患者术前有严重二尖瓣反流(MR)。在这11例患者中,5例(45%[11例中的5例])在ALCAPA修复时同时进行了MV修复,3例(27%[11例中的3例])进行了晚期MV修复或置换,其余3例(27%[11例中的3例])患者在最后一次随访时患有轻度MR。在最后一次随访时,36例(90%[41例中的36例])患者左心室功能正常,4例(10%[41例中的4例])患者左心室(LV)功能轻度降低。
ALCAPA手术可取得良好效果。持续性MR和较高的晚期MV修复率需要密切随访。